TAZ 抗体 (AA 386-390)
Quick Overview for TAZ 抗体 (AA 386-390) (ABIN5689355)
抗原
See all TAZ 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 386-390
-
特异性
- This antibody detects endogenous level of total TAZ protein.
-
纯化方法
- Antibodies were purified by affinity-chromatography using epitope-specific peptide.
-
免疫原
- TAZ antibody was raised against a peptide sequence around aa.386~390 (V-E-S-A-L) derived from Human TAZ.
-
-
-
-
应用备注
- Western Blot: 1:500~1:1000
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 mg/mL
-
缓冲液
- Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store antibody at -20°C for up to one year.
-
-
- TAZ (Tafazzin (TAZ))
-
别名
- TAZ
-
背景
- Transcriptional coactivator which acts as a downstream regulatory target in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein MST1/MST2, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. WWTR1 enhances PAX8 and NKX2-1/TTF1-dependent gene activation. Regulates the nuclear accumulation of SMADS and has a key role in coupling them to the transcriptional machinery such as the mediator complex. Regulates embryonic stem-cell self-renewal, promotes cell proliferation and epithelial-mesenchymal transition.
-
分子量
- 49 kDa
-
基因ID
- 25937
-
NCBI登录号
- NP_001161750
-
UniProt
- Q9GZV5
抗原
-